etomoxir has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitahara, M; Naitoh, T; Tsuruzoe, N; Yotsumoto, T | 1 |
| Rupp, H; Vetter, R | 1 |
2 other study(ies) available for etomoxir and Hypertrophy
| Article | Year |
|---|---|
Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy.
Topics: Acyl Coenzyme A; Animals; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Heart; Humans; Hypertrophy; Liver; Male; Mice; Mitochondria, Heart; Mitochondria, Liver; Myocardium; Organophosphonates; Time Factors; Triglycerides; Tumor Cells, Cultured | 2000 |
Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.
Topics: Animals; Aortic Valve Stenosis; Body Weight; Calcium; Calcium-Transporting ATPases; Carnitine O-Palmitoyltransferase; Disease Progression; Enzyme Inhibitors; Epoxy Compounds; Heart Failure; Heart Ventricles; Hypertrophy; Isoenzymes; Myosins; Organ Size; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Time Factors | 2000 |